Chronic neutropenia in LGL leukemia and rheumatoid arthritis
- 8 December 2017
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2017 (1) , 181-186
Abstract
This section reviews the diagnostic criteria and pathogenesis of large granular lymphocyte (LGL) leukemia. There is a particular focus on the overlap of LGL leukemia and rheumatoid arthritis (Felty's syndrome). Current understanding of the mechanisms of neutropenia in these disorders is discussed. Finally, treatment indications and therapeutic recommendations are outlined.Keywords
This publication has 46 references indexed in Scilit:
- Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationBlood Cancer Journal, 2013
- The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexesEMBO Molecular Medicine, 2012
- The spectrum of large granular lymphocyte leukemia and Feltyʼs syndromeCurrent Opinion in Hematology, 2011
- How I treat LGL leukemiaBlood, 2011
- Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 casesHaematologica, 2010
- Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathwayBlood, 2010
- Network model of survival signaling in large granular lymphocyte leukemiaProceedings of the National Academy of Sciences, 2008
- Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopeniaExperimental Hematology, 2008
- Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytesBlood, 2008
- Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemiaBlood, 2008